Patent · US Active

Vaccines comprising leishmania polypeptides for the treatment and diagnosis of leishmaniasis

US9909114B2 · kind B2 · utility

0Cited by

47References

23Claims

0Family size

Assignee

INFECTIOUS DISEASE RESEARCH INSTITUTE · US

Inventors

Malcolm Duthie · Sammamish, US
Jeff Guderian · Lynnwood, US
Steven G. Reed · Bellevue, US

Key dates

Filing date	Mar 28, 2014
Grant date	Mar 6, 2018
Priority date	—
Expiry date	Apr 30, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions and methods for preventing, treating and detecting leishmaniasis are disclosed. The compositions generally comprise polypeptides comprising Leishmania antigens as well as polynucleotides encoding such polypeptides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.